Reirradiation in pelvic malignancies

Phase 2

Recruiting

• Conditions: Condition 1: Local recurrence of rectal cancer in pelvis. Condition 2: Local recurrence of cervical cancer in pelvis. Condition 3: Local recurrence of endometrial cancer in pelvis.; Malignant neoplasm of rectum; Malignant neoplasm of cervix uteri; Malignant neoplasm of endometrium; C54.1

• Registration Number: IRCT20220130053877N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Local recurrence of rectum, cervix and endometrial cancer
Inoperable patients or needs neoadjuvant reirradiation for better resection or adjuvant reirradiation for better control
More than 6 month after previous course of radiation

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
rinary complications. Timepoint: 1 week, 1 month, 3 month & 6 month after last session of reirradiation. Method of measurement: Common Terminology Criteria for Adverse Events (CTCAE) Version ?.?.;Gastrointestinal complications. Timepoint: 1 week, 1 month, 3 month & 6 month after last session of reirradiation. Method of measurement: Common Terminology Criteria for Adverse Events (CTCAE) Version ?.?.;Skin and soft tissue complications. Timepoint: 1 week, 1 month, 3 month & 6 month after last session of reirradiation. Method of measurement: Common Terminology Criteria for Adverse Events (CTCAE) Version ?.?.